WNT10B
WNT10B (Wnt family member 10B, also known as WNT-12 or SHFM6) is a secreted Wnt family ligand that activates canonical Wnt/beta-catenin signalling. It contributes to signalling networks that control stemness, pluripotency and cell fate decisions. Browse Assay Genie's current range of WNT10B research reagents below, or read on for the biology behind the target.
WNT10B is a member of the Wnt ligand family, which encodes secreted proteins that activate the Wnt signalling cascade. It acts specifically on the canonical Wnt/beta-catenin pathway, and so triggers beta-catenin/LEF/TCF-mediated transcriptional programmes. These programmes sit within signalling networks that govern stemness, pluripotency and cell fate decisions. Annotated activity of the WNT10B protein spans the immune system, mammary gland, adipose tissue, bone and skin. Subcellular annotation places it in the extracellular space and extracellular matrix, consistent with its role as a secreted signalling molecule.
The WNT gene family consists of structurally related genes encoding secreted signalling proteins. These have been implicated in oncogenesis and in developmental processes, including regulation of cell fate and patterning during embryogenesis. The WNT10B gene lies at 12q13.12 and is clustered with another family member, WNT1, in the 12q13 region. The human protein is 96% identical at the amino acid level to mouse Wnt10b, which makes the mouse a natural comparison model for functional studies.
NCBI Gene notes that WNT10B may be involved in breast cancer, and that its signalling is likely a molecular switch governing adipogenesis. The gene was previously named wingless-type MMTV integration site family, member 10B, and the alias SHFM6 and symbol WNT-12 appear in the literature. Related Wnt ligands such as WNT10A, WNT1 and Wnt3a are often studied alongside it when dissecting ligand-specific effects on the Wnt pathway.
WNT10B specifically activates Wnt/beta-catenin signalling and beta-catenin/LEF/TCF-driven transcription, making it a useful ligand for studying this pathway.
Its signalling is likely a molecular switch that governs adipogenesis, linking WNT10B to studies of adipose tissue biology.
WNT10B participates in signalling networks controlling stemness, pluripotency and cell fate decisions, relevant to developmental and stem cell work.
The WNT10B gene may be involved in breast cancer, and Wnt proteins have been implicated more broadly in oncogenesis.
WNT10B is a secreted ligand that specifically activates canonical Wnt/beta-catenin signalling, triggering beta-catenin/LEF/TCF-mediated transcriptional programmes. It contributes to control of stemness, pluripotency and cell fate, and acts in the immune system, mammary gland, adipose tissue, bone and skin.
WNT10B is the HGNC symbol for Wnt family member 10B, with the UniProt name Protein Wnt-10b. Aliases include WNT-12 and SHFM6, and the earlier gene name was wingless-type MMTV integration site family, member 10B.
The human WNT10B protein is 96% identical to mouse Wnt10b at the amino acid level, according to NCBI Gene. This high conservation supports the use of mouse models, though you should check the datasheet of any product for its validated reactivity.
Other Wnt family ligands and pathway-related targets that are often studied alongside WNT10B.
Gene and protein annotations from HGNC, NCBI Gene and UniProt O00744; product specifications from Assay Genie datasheets.